Differential effects of some cell signalling inhibitors upon nitric oxide synthase expression and nuclear factor-κB activation induced by lipopolysaccharide in rat aortic smooth muscle cells

Pharmacological Research

Volumn 39, Issue 5, 1999, Pages 363-373

  Zhou, J ^a,b   Struthers, A D ^a   Lyles, G A ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Lipopolysaccharide; NF B; Nitric oxide synthase; Rat aorta; Vascular smooth muscle cells

Indexed keywords

APOCYNIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; LIPOXYGENASE INHIBITOR; NITRIC OXIDE SYNTHASE; NITRITE; NORDIHYDROGUAIARETIC ACID; PROTEASOME INHIBITOR; PYRROLIDINE DITHIOCARBAMATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TOSYLPHENYLALANYL CHLOROMETHYL KETONE;

ANIMAL CELL; AORTA MEDIA; ARTICLE; CONTROLLED STUDY; DENSITOMETRY; DNA BINDING; DRUG EFFECT; ELECTROPHORESIS; GENETIC TRANSCRIPTION; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

EID: 0033136746     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1998.0450     Document Type: Article

References (49)

1. Griffith OW, Stuehr DJ. Nitric oxide synthases: Properties and catalytic mechanism. Annu Rev PhysIol 1995; 57: 707-36.
2. Gross SS, Wolin MS. Nitric oxide: Pathophysiological mechanisms. Annu Rev Physiol 1995; 57: 737-69.
3. MacMicking J, Xie QW, Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol 1997; 15: 323-50.
4. Ketteler M, Cetto C, Kirdorf M, Jesche GS, Schafer JH, Distler A. Nitric oxide in sepsis-syndrome: Potential treatment of septic shock by nitric oxide synthase antagonists. Kidney Int Suppl 1998; 64: S27-30.
5. Sherman MP, Aeberhard EE, Wong VZ, Griscavage JM, Ignarro LJ. Pyrrolidine dithiocarbamate inhibits induction of nitric oxide synthase in rat alveolar macrophages. Biochem Biophys Res Commun 1993; 191: 1301-8.
6. Xie QW, Kashiwabara Y, Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem 1994; 269: 4705-8.
7. Hecker M, Preiß C, Klemm P, Busse R. Inhibition by antioxidants of nitric oxide synthase expression in murine macrophages: Role of nuclear factor κB and interferon regulatory factor 1. Br J Pharmacol 1996; 118: 2178-84.
8. Eberhardt W, Kunz D, Pfeilschifter J. Pyrrolidine dithiocarbamate differently affects interleukin-1β and cAMP-induced nitric oxide synthase expression in rat renal mesangial cells. Biochem Biophys Res Commun 1994; 20: 163-70.
9. Adcock IM, Brown CR, Kwon O, Barnes PJ. Oxidative stress induces NFκB DNA binding and inducible iNos mRna in human epithelial cells. Biochem Biophys Res Commun 1994; 199: 1518-24.
10. Oddis CV, Finkel MS. NF-κB and GTP cyclohydrolase regulate cytokine-induced nitric oxide production by cardiac myocytes. Am J Physiol 1996; 270: H1864-8.
11. Duval DL, Miller DR, Collier J, Billings RE. Characterization of hepatic nitric oxide synthase: Identification as the cytokine-inducible form primarily regulated by oxidants. Mol Pharmacol 1996; 50: 277-84.
12. Kleinert H, Euchenhofer C, Ihrig-Biedert I, Forstermann U. Glucocorticoids inhibit the induction of nitric oxide synthase II by down-regulating cytokine-induced activity of transcription factor nuclear factor-κB. Mol Pharmacol 1996; 49: 15-21.
13. Feinstein DL, Galea E, Aquino DA, Li GC, Xu H, Reis DJ. Heat shock protein 70 suppresses astroglial-inducible nitric-oxide synthase expression by decreasing NFkappaB activation. J Biol Chem 1996; 271: 17724-32.
14. Schini-Kerth V, Bara A, Mulsch A, Busse R. Pyrrolidine dithiocarbamate selectively prevents the expression of the inducible nitric oxide synthase in the rat aorta. Eur J Pharmacol 1994; 265: 83-7.
15. Schini-Kerth VB, Boese M, Fisslthaler B, Mulsch A. N-α-tosyl-L-lysine chloromethylketone prevents expression of iNos in vascular smooth muscle by blocking activation of NF-κB. Arterioscler Thromb Vasc Biol 1997; 17: 672-9.
16. Wong HR, Finder JD, Wasserloos K, Lowenstein CJ, Geller DA, Billiar TR, Pitt BR, Davies P. Transcriptional regulation of iNos by IL-1β in cultured rat pulmonary artery smooth muscle cells. Am J Physiol 1996; 271: L166-71.
17. Szabo C, Mitchell JA, Gross SS, Thiemermann C, Vane JR. Nifedipine inhibits the induction of nitric oxide synthase by bacterial lipopolysaccharide. J Pharmacol Exp Ther 1993; 265: 674-80.
18. Hattori Y, Szabo C, Gross SS, Thiemermann C, Vane JR. Lipid A and the lipid A analogue antitumour compound ONO-4007 induce nitric oxide synthase in vitro and in vivo. Eur J Pharmacol 1995; 291: 83-90.
19. Paul A, Doherty K, Plevin R. Differential regulation by protein kinase C isoforms of nitric oxide synthase induction in RAW 264.7 macrophages and rat aortic smooth muscle cells. Br J Pharmacol 1997; 120: 940-6.
20. Zhou J, Struthers AD, Lyles GA. Lipopolysaccharide-induced nitrite formation in rat anococcygeus cultured smooth muscle cells. Br J Pharmacol 1996; 119: 314P.
21. Zhou J, Struthers AD, Lyles GA. Effects of signal transduction inhibitors upon lipopolysaccharide-induced nitrite formation in rat aortic cultured smooth muscle cells. Br J Pharmacol 1996; 119: 315P.
22. Zhou J, Struthers AD, Lyles GA. Effects of bacterial lipopolysaccharide treatment on NF-κB activity in cultured rat aortic smooth muscle cells. Br J PharmaCol 1997; 122: 372P.
23. Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63.
24. Schreck R, Meier B, Männel DN, Dröge W, Bauerle PA. Dithiocarbamates as potent inhibitors of nuclear factor κB activation in intact cells. J Exp Med 1992; 175: 1181-94.
25. Henkel T, Machleidt T, Alkalam I, Kronke M, Benneriah Y, Bauerle PA. Rapid proteolysis of IκB is necessary for activation of transcription factor NF-κB. Nature 1993; 365: 182-5.
26. Salari H, Braquet P, Borgeat P. Comparative effects of indomethacin, acetylenic acids, 15-HETE, nordihydroguaiaretic acid and BW755C on the metabolism of arachidonic acid in human leucocytes and platelets. Prostaglandins Leukot Med 1984; 13: 53-60.
27. Stolk J, Hiltermann TJ, Dijkman JH, Verhoeven AJ. Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol. Am J Respir Cell Mol Biol 1994; 11: 95-102.
28. Baldwin AS. The NF-κB and IκB proteins: New discoveries and insights. Annu Rev Immunol 1996; 14: 649-81.
29. Lawrence R, Chang L-J, Siebenlist W, Bressler P, Sonenshein GE. Vascular cells express a constitutive NF-κB-like activity. J Biol Chem 1994; 269: 28913-18.
30. Obata H, Biro S, Arima N, Kaieda H, Kihara T, Eto H, Miyata M, Tanaka H. NF-κB is induced in the nuclei of cultured rat aortic smooth muscle cells by stimulation of various growth factors. Biochem BioPhys Res Commun 1996; 224: 27-32.
31. Hecker M, Preiß C, Schini-Kerth VB, Busse R. Antioxidants differentially affect nuclear factor κB-mediated nitric oxide synthase expression in vascular smooth muscle cells. FEBS Lett 1996; 380: 224-8.
32. Brennan P, O'Neill LAJ. Effects of oxidants and antioxidants on nuclear factor κB activation in three different cell lines: Evidence against a universal hypothesis involving oxygen radicals. Biochim Biophys Acta 1995; 1260: 167-75.
33. Kleinert H, Euchenhofer C, Ihrig-Biedert I, Forstermann U. In murine 3T3 fibroblasts, different second messenger pathways resulting in the induction of NO synthase II (iNos) converge in the activation of transcription factor NF-κB. J Biol Chem 1996; 271: 6039-44.
34. Kwon G, Corbett JA, Rodi CP, Sullivan P, McDaniel ML. Interleukin-1β-induced nitric oxide synthase expression by rat pancreatic β-cells: Evidence for the involvement of nuclear factor κB in the signalling mechanism. Endocrinology 1995; 136: 4790-5.
35. Hattori Y, Nakanishi N, Kasai K, Shimoda S-I, Gross SS. Pyrrolidine dithiocarbamate inhibits immunostimulant-induced tetrahydrobiopterin synthesis in rat vascular smooth muscle. Eur J Pharmacol 1996; 296: 107-12.
36. Tetsuka T, Baier LD, Morrison AR. Antioxidants inhibit interleukin-1-induced cyclooxygenase and nitric-oxide synthase expression in rat mesangial cells. Evidence for post-translational regulation. J Biol Chem 1996; 271: 11689-93.
37. Griscavage JM, Wilk S, Ignarro LJ. Inhibitors of the proteasome pathway interfere with induction of nitric oxide synthase in macrophages by blocking activation of transcription factor NF-κB. Proc Natl Acad Sci USA 1996; 93: 3308-12.
38. Imai Y, Kolb H, Burkart V. Nitric oxide production is regulated by arachidonic acid metabolites. Biochem Biophys Res Commun 1993; 197: 105-9.
39. Ryoyama K, Nomura T, Nakamura S. Inhibition of macrophage nitric oxide production by arachidonate-cascade inhibitors. Cancer Immunol Immunother 1993; 37: 385-91.
40. 2 metabolites regulate inducible nitric oxide synthase in myocytes. Hypertension 1988; 31: 218-24.
41. 4 transcriptionally activates interleukin-6 expression involving NF-κB and NF-IL6. Eur J Immunol 1992; 22: 2705-11.
42. Los M, Schenk H, Hexel K, Bauerle PA, Droge W, Schulze-Osthoff K. IL-2 gene expression and NF-κB activation through CD28 require reactive oxygen production by 5-lipoxygenase. EMBO J 1995; 14: 3731-40.
43. Camandola S, Leonarduzzi G, Tiziana M, Varesio L, Carini R, Scavazza A, Chiarpotto E, Bauerle PA, Poli G. Nuclear factor κB is activated by arachidonic acid but not by eicosapentaenoic acid. Biochem Biophys Res Commun 1996; 229: 643-7.
44. Faux SP, Howden PJ. Possible role of lipid peroxidation in the induction of NF-κB and AP-1 in RFL-6 cells by crocidolite asbestos: Evidence following protection by vitamin E. Environ Health Perspect 1997; 105 (Suppl. 5): 1127-30.
45. Lee S, Felts KA, Parry GC, Armacost LM, Cobb RR. Inhibition of 5-lipoxygenase blocks IL-1β-induced vascular adhesion molecule-1 gene expression in human endothelial cells. J Immunol 1997; 158: 3401-7.
46. Ahmad M, Theofanidis P, Medford RM. Role of activating protein-1 in the regulation of the vascular cell adhesion molecule-1 gene expression by tumour necrosis factor-α. J Biol Chem 1998; 273: 4616-21.
47. Hecker M, Preiß C, Schini-Kerth VB. Induction by staurosporine of nitric oxide synthase expression in vascular smooth muscle cells: Role of NF-κB, CREB and C/EPBβ. Br J Pharmacol 1997; 120: 1067-74.
48. Satriano JA, Shuldiner M, Hora K, Xing Y, Shan Z, Schlondorff D. Oxygen radicals as second messengers for expression of the monocyte chemoattractant protein, JE/MCP-1, and the monocyte colony-stimulating factor, CSF-1, in response to tumor necrosis factor-α and immunoglobulin G. Evidence for involvement of reduced nicotinamide adenine dinucleotide phosphate (NADPH)-dependent oxidase. J Clin Invest 1993; 92: 1564-71.
49. phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem 1996; 271: 23317-21.